Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Clinical trial NCT06399640 · RECRUITING

Trial details

NCT number: NCT06399640
Sponsor: Vanderbilt-Ingram Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Myelodysplastic Syndrome Refractory Myelodysplastic Syndrome Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2024-08-14
Primary completion: 2027-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.